"The
Report Left Ventricular Dysfunction - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Summary
Global
Markets Directs, Left
Ventricular Dysfunction
- Pipeline Review, H2 2016, provides an overview of the Left
Ventricular Dysfunction pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Left Ventricular Dysfunction, complete with analysis
by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also
covers the descriptive pharmacological action of the therapeutics,
its complete research and development history and latest news and
press releases. Additionally, the report provides an overview of key
players involved in therapeutic development for Left Ventricular
Dysfunction and features dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at:
Scope
- The report provides a snapshot of the global therapeutic landscape
of Left Ventricular Dysfunction
- The report reviews pipeline therapeutics for Left Ventricular
Dysfunction by companies and universities/research institutes based
on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
- The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved Left Ventricular
Dysfunction therapeutics and enlists all their major and minor
projects
- The report assesses Left Ventricular Dysfunction therapeutics based
on drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline
projects
- The report reviews latest news related to pipeline therapeutics for
Left Ventricular Dysfunction
Reasons to buy
- Gain strategically significant competitor information, analysis,
and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics
under development for Left Ventricular Dysfunction
- Identify potential new clients or partners in the target
demographic
- Develop strategic initiatives by understanding the focus areas of
leading companies
- Plan mergers and acquisitions effectively by identifying key
players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding
Left Ventricular Dysfunction pipeline depth and focus of Indication
therapeutics
- Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from pipeline
Table
Of Content
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Left
Ventricular Dysfunction Overview 6
Therapeutics
Development 7
Pipeline
Products for Left Ventricular Dysfunction - Overview 7
Left
Ventricular Dysfunction - Therapeutics under Development by Companies
8
Left
Ventricular Dysfunction - Pipeline Products Glance 9
Late
Stage Products 9
Clinical
Stage Products 10
Early
Stage Products 11
Left
Ventricular Dysfunction - Products under Development by Companies 12
Left
Ventricular Dysfunction - Companies Involved in Therapeutics
Development 13
Amgen
Inc. 13
Bayer
AG 14
Capricor
Therapeutics, Inc. 15
Innopharmax
Inc. 16
Les
Laboratoires Servier SAS 17
Quantum
Genomics SA 18
RedHill
Biopharma Ltd. 19
TiGenix
NV 20
Left
Ventricular Dysfunction - Therapeutics Assessment 21
Assessment
by Monotherapy Products 21
Assessment
by Target 22
Assessment
by Mechanism of Action 24
Assessment
by Route of Administration 26
Assessment
by Molecule Type 28
Drug
Profiles 30
BAY-1142524
- Drug Profile 30
Product
Description 30
Mechanism
Of Action 30
R&D
Progress 30
CAP-1001
- Drug Profile 31
Product
Description 31
Mechanism
Of Action 31
R&D
Progress 31
CAP-1002
- Drug Profile 32
Product
Description 32
Mechanism
Of Action 32
R&D
Progress 32
carvedilol
CR - Drug Profile 37
Product
Description 37
Mechanism
Of Action 37
R&D
Progress 37
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment